Description

PENTOP is indicated in adults and adolescents aged 12 years and older for:

Symptomatic gastroesophageal reflux disease.

Maintenance treatment and prevention of recurrence of reflux esophagitis.

PENTOP is indicated in adults for:

Prevention of non-selective nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcers in at-risk patients requiring continued NSAID treatment